Literature DB >> 7542313

Increased nitric oxide synthase activities and L-[3H]arginine uptake in brain following portacaval anastomosis.

V L Rao1, R M Audet, R F Butterworth.   

Abstract

Glutamatergic synaptic dysfunction has been proposed as a causal factor in portal-systemic encephalopathy. Increased in vitro and in vivo glutamate release and decreased glutamate binding to NMDA receptors were previously reported in the brains of portacaval-shunted rats. Such changes could lead to alterations in the second messenger systems coupled to glutamate receptors. As NMDA receptors have been shown to act via the nitric oxide/cyclic GMP second messenger system, we studied the activities of constitutive nitric oxide synthase (NOS) in the brains of rats following portacaval shunting. Results demonstrate that NOS activities are significantly increased in cerebellum (by 54%, p < 0.01), cerebral cortex (by 65%, p < 0.01), hippocampus (by 88%, p < 0.01), and striatum (by 64%, p < 0.01) of shunted rats compared with sham-operated controls. As L-arginine transport is a prerequisite for nitric oxide production, we also studied L-[3H]arginine transport into cerebellar and cerebral cortical synaptosomes prepared from the brains of portacaval-shunted and sham-operated rats. L-[3H]Arginine uptake was significantly increased (by approximately 50%, p < 0.01) in both cerebellum and cortex. Increased NOS activities of neuronal and/or astrocytic origin and the resultant increased production of nitric oxide in brain could be the consequence of increased NMDA receptor activation following portacaval shunting. Furthermore, increased nitric oxide production could contribute to the increased cerebral blood flow consistently observed following portacaval shunting.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542313     DOI: 10.1046/j.1471-4159.1995.65020677.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

1.  Regional distribution of binding sites for the nitric oxide synthase inhibitor L-[3H]nitroarginine in rat brain.

Authors:  V L Rao; R F Butterworth
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

Review 2.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 3.  Neural synchronization in hepatic encephalopathy.

Authors:  Lars Timmermann; Markus Butz; Joachim Gross; Gerald Kircheis; Dieter Häussinger; Alfons Schnitzler
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 4.  Neuronal cell death in hepatic encephalopathy.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 5.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

6.  Neuroactive amino acids in hepatic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

7.  Ammonia and manganese increase arginine uptake in cultured astrocytes.

Authors:  A S Hazell; M D Norenberg
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

Review 8.  Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism.

Authors:  Eric M Liotta; W Taylor Kimberly
Journal:  Neurosci Lett       Date:  2020-02-05       Impact factor: 3.046

9.  Hyperammonemia, brain edema and blood-brain barrier alterations in prehepatic portal hypertensive rats and paracetamol intoxication.

Authors:  Camila Scorticati; Juan P Prestifilippo; Francisco X Eizayaga; José L Castro; Salvador Romay; María A Fernández; Abraham Lemberg; Juan C Perazzo
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

10.  Induction of NOS and nitrotyrosine expression in the rat striatum following experimental hepatic encephalopathy.

Authors:  Isabel Suárez; Guillermo Bodega; Miguel Rubio; Benjamín Fernández
Journal:  Metab Brain Dis       Date:  2009-09       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.